Safety and Immunogenicity of DAPTACEL (CP10/5/5/3DT Aventis Pasteur 5-Component Pertussis Vaccine in Combination With Tetanus and Diphtheria Toxoids Adsorbed) Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL (HCP20/20/5/3DT-mIPV//PRP-T).
Phase of Trial: Phase IV
Latest Information Update: 04 Apr 2014
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi
- 09 Dec 2008 New trial record.